Linola Akut (Prednisolone, Salicylic Acid)

Prednisolone acts as a glucocorticoid receptor agonist. After penetrating the skin, it binds to intracellular receptors and alters gene transcription, leading to decreased production of pro‑inflammatory cytokines, chemokines and adhesion molecules. This results in reduced swelling, redness and immune cell infiltration at the site of application.

The dosage of Linola Akut is individualized. A qualified prescriber determines the amount, frequency and duration based on the specific skin condition, severity and patient factors. Patients should follow the healthcare professional’s instructions and not exceed the prescribed regimen.

Safety data for topical prednisolone and salicylic acid during pregnancy or lactation are limited. Use only if the potential benefit justifies any potential risk to the fetus or infant. Women who are pregnant, planning pregnancy or breastfeeding should discuss use with their physician.

To order Linola Akut, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets. The sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details and any required import documentation.

Linola Akut offers the combined benefits of a corticosteroid and a keratolytic in a single formulation. Prednisolone alone provides anti‑inflammatory action, while salicylic acid alone promotes exfoliation. The combination can enhance therapeutic efficacy, reduce the need for multiple products, and improve patient convenience, especially for conditions featuring both inflammation and scaling.

Store Linola Akut at room temperature, preferably below 25 °C, in the original packaging. Protect it from excessive moisture, direct sunlight and extreme heat. Keep the container tightly closed when not in use to maintain product stability.

Linola Akut is applied topically to the affected skin area. Clean and gently dry the area, then spread a thin layer of the product using clean fingertips or a sterile applicator. Follow the prescriber’s recommended frequency, typically once or twice daily, and wash hands after application.

Serious risks include systemic corticosteroid effects such as adrenal suppression, especially with extensive or prolonged use, and skin atrophy or telangiectasia. Secondary infections (bacterial, fungal or viral) can develop if the barrier function is compromised. Rarely, severe allergic reactions like angioedema or anaphylaxis may occur.

Linola Akut should be avoided in individuals with known hypersensitivity to prednisolone, salicylic acid, or any excipients in the formulation. It is also contraindicated on large areas of broken, infected or ulcerated skin, and in patients with systemic fungal infections or uncontrolled diabetes without medical supervision.